Dr. Reddy’s Laboratories, the second largest pharmaceutical company in India, has launched esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of AstraZeneca Ab Corporation's Nexium (esomeprazole magnesium) delayed-release capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (US FDA).
The Nexium (esomeprazole magnesium) delayed-release capsules brand and generic had US sales of approximately $5.2 billion MAT for the most recent twelve months ending in July 2015, according to IMS Health.
Dr. Reddy’s esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg are available in bottle count size of 30.